| Ingredient Category | Example Compounds | Proposed Effect | |---------------------|------------------|------------------| | Stimulants | Caffeine (200–300 mg), DMHA, Octodrine | Increased alertness, aggression, pain tolerance | | Nitric Oxide Precursors | L-Citrulline, Nitrosigine | Vasodilation, muscle pumps, vascularity | | Nootropics | Alpha-GPC, Huperzine A | Focus, mind-muscle connection | | Beta-Alanine | 1.5–3.2 g | Delayed muscular fatigue, paresthesia (tingling) | | Yohimbine | 2–5 mg | Fat burning via alpha-2 antagonism, but with cardiovascular risk | | Proprietary Blends | “NMT,” “Eria Jarensis extract” | “Euphoric” energy (dopaminergic) |
| Ingredient Category | Example Compounds | Proposed Effect | |---------------------|------------------|------------------| | Stimulants | Caffeine (200–300 mg), DMHA, Octodrine | Increased alertness, aggression, pain tolerance | | Nitric Oxide Precursors | L-Citrulline, Nitrosigine | Vasodilation, muscle pumps, vascularity | | Nootropics | Alpha-GPC, Huperzine A | Focus, mind-muscle connection | | Beta-Alanine | 1.5–3.2 g | Delayed muscular fatigue, paresthesia (tingling) | | Yohimbine | 2–5 mg | Fat burning via alpha-2 antagonism, but with cardiovascular risk | | Proprietary Blends | “NMT,” “Eria Jarensis extract” | “Euphoric” energy (dopaminergic) |